Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Cap	25.23B +12.2%
Revenue (ttm)	164.16B +7.0%
Net Income	2.02B -31.3%
EPS	0.39 -32.5%
Shares Out	4.99B
PE Ratio	12.93
Forward PE	14.53
Dividend	0.20 (3.91%)
Ex-Dividend Date	Jun 17, 2025

Volume	30,153,829
Average Volume	38,158,823
Open	5.05
Previous Close	5.06
Day's Range	5.02 - 5.09
52-Week Range	4.81 - 5.84
Beta	0.24
RSI	37.25
Earnings Date	Apr 28, 2026

About SHA:600998

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 30,169
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2025, SHA:600998's revenue was 161.39 billion, an increase of 6.31% compared to the previous year's 151.81 billion. Earnings were 2.25 billion, a decrease of -10.07%.